AzTrials
AzTrials

BreastfeedingMIM-BONDNCT07867054

Effects of Maternal and Infant Massage on Breastfeeding and Mother-Infant Bonding

A study testing Infant Massage, Oxytocin Massage and Infant Massage and Oxytocin Massage in people with Breastfeeding and Mother-Infant Bonding, run by Istanbul University - Cerrahpasa.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

This study aims to evaluate the effects of different massage techniques applied to mothers and infants on breastfeeding parameters and mother-infant bonding during the postpartum period. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Breastfeeding, Mother-Infant Bonding, Lactation
What is being tested?
Infant Massage, Oxytocin Massage and Infant Massage and Oxytocin Massage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
136 participants
Where
No sites listed yet
Study dates
1 Nov 2026to 1 Aug 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Mother:
  • Being primiparous.
  • Being within the first 24 hours postpartum.
  • Having a singleton birth.
  • Rooming-in with her infant during the postpartum period.
  • Having no physical or mental health condition that would prevent breastfeeding or participation in the study.
Show all 16Show fewer
  • Being willing to regularly administer infant massage to her infant for 4 weeks postpartum.
  • Having no health condition that would prevent the mother or infant from receiving massage.
  • Being able to speak Turkish and having no condition that would interfere with communication.
  • Father:
  • Being present with the mother during the postpartum period.
  • Being able to speak Turkish and having no condition that would interfere with communication.
  • Being able to regularly administer oxytocin massage to the mother for 4 weeks postpartum.
  • Infant:
  • Being born at term (37-42 weeks of gestation).
  • Having a birth weight between 2,500 and 4,000 g.

Who cannot join

  • The mother cannot be reached at 4 weeks postpartum.
  • Infant massage is performed fewer than twice per week.
  • Oxytocin massage is performed fewer than twice per week.
  • The infant is admitted to the neonatal intensive care unit.
  • The mother develops a postpartum complication (e.g., postpartum hemorrhage or suspected infection).
  • Participants assigned to the oxytocin massage group administer infant massage.
  • Participants assigned to the infant massage group administer oxytocin massage.
  • Participants assigned to the control group administer either oxytocin massage or infant massage.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Özge Şen, PhD contact

05393644201

ozgeylmz53@gmail.com

About this study

Official title: The Effect of Different Massage Techniques Applied to Mother and Baby on Breastfeeding Parameters and Mother-Baby Bonding

This study aims to evaluate the effects of different massage techniques applied to mothers and infants on breastfeeding parameters and mother-infant bonding during the postpartum period. The study will investigate whether infant massage applied by mothers, oxytocin massage applied to mothers by fathers, or the combination of both interventions improves breastfeeding outcomes and mother-infant bonding compared with standard postpartum care.

Read the detailed description

The postpartum period is a critical period during which mothers and newborns adapt to important physiological, psychological, and social changes . During this period, maternal postpartum recovery, neonatal adaptation to life, successful initiation of breastfeeding, and the development of the mother-infant relationship are interrelated processes. In particular, the first hours and days after birth are critical for establishing breastfeeding behaviors, regulating milk production, and strengthening mother-infant interaction. Initiation of breastfeeding during the first hours after birth is one of the key practices supporting the newborn's access to colostrum, early immune protection, and the continuation of breastfeeding.

Lactation is a complex physiological process involving preparation of the breast for breastfeeding, milk synthesis and secretion, milk ejection (let-down) reflex, and maintenance of lactation. Effective infant suckling and regular breast emptying are important for successful continuation of this process. Inadequate breastfeeding may lead to decreased prolactin levels and adversely affect milk production. However, breastfeeding success cannot be explained solely by physiological mechanisms; it is influenced by multiple factors, including maternal knowledge, breastfeeding beliefs, sources of social support, childbirth experience, and breastfeeding self-efficacy.

Breastfeeding self-efficacy is defined as a mother's confidence in her ability to breastfeed her infant successfully and is considered an important determinant of breastfeeding initiation and continuation. Maternal education level, mode of delivery, postpartum care experiences, social support, and breastfeeding-related concerns may influence breastfeeding self-efficacy. In addition, hormonal changes, physical fatigue, sleep deprivation, adjustment to the maternal role, and concerns related to infant care may increase maternal stress during the postpartum period. Increased stress and anxiety may adversely affect oxytocin release and the milk ejection reflex, potentially resulting in reduced milk flow, shorter breastfeeding duration, and decreased maternal confidence in breastfeeding.

Therefore, there is a need for safe, feasible, and low-cost postpartum care interventions that address mothers' physiological and psychological needs. Oxytocin massage is a non-pharmacological complementary intervention used to support breast milk production and milk ejection. Oxytocin massage consists of circular massage movements applied along the neck, scapular, and spinal areas for approximately 15-20 minutes. It has been suggested that this intervention may stimulate the central nervous system through cutaneous and neural pathways, thereby increasing oxytocin release through the hypothalamic-pituitary pathway and supporting the milk ejection reflex. Previous studies have reported that oxytocin massage may have beneficial effects on milk volume, milk flow, and breastfeeding outcomes.

Another non-pharmacological intervention that may support mother-infant interaction is infant massage. Infant massage is an easily applicable caregiving approach that increases tactile communication between the mother and infant and may support the infant's physiological and behavioral regulation. Infant massage has been reported to increase vagal activity and potentially improve gastrointestinal function, nutrient absorption, and growth. Increased vagal activity may influence gastrin and insulin levels, potentially facilitating more efficient utilization of nutrients and supporting infant weight gain. In addition, by promoting infant relaxation and supporting sucking behaviors, infant massage may increase breastfeeding frequency, which may in turn stimulate prolactin secretion and contribute to milk production.

Infant massage may have beneficial effects not only on infant physical development but also on the mother-infant relationship. According to attachment theory, the mother-infant relationship begins at birth and develops through the mother's sensitive responsiveness to the infant's needs and reciprocal communication. Positive tactile contact during infant massage has been reported to support secure attachment, increase maternal sensitivity toward the infant, and strengthen mother-infant interaction.

The literature indicates that the effects of oxytocin massage and infant massage on breastfeeding, milk production, infant development, and mother-infant interaction have generally been evaluated separately. However, randomized controlled studies examining the effects of combining maternal oxytocin massage with infant massage performed by mothers on breastfeeding parameters, breastfeeding self-efficacy, and mother-infant bonding are limited. Since breastfeeding is a dynamic process shaped not only by maternal physiological factors but also by reciprocal mother-infant interaction, evaluating the effects of integrated tactile approaches targeting both the mother and infant is important.

This study is designed to evaluate the effects of maternal oxytocin massage and infant massage performed by mothers, when applied separately and in combination, on breastfeeding scores, time to breastfeeding initiation, breastfeeding duration and frequency, breastfeeding status at hospital discharge, breastfeeding problems, infant feeding method, breastfeeding self-efficacy, and mother-infant bonding during the postpartum period.

The originality of this study lies in its four-arm randomized controlled design, which comparatively evaluates two different non-pharmacological interventions targeting the mother and infant, both individually and in combination. This approach aims to provide evidence for a holistic model of postpartum care that considers the mother and infant together and to contribute new evidence to postpartum care practices.

The findings of this study are expected to contribute to the development of evidence-based interventions that can be implemented by midwives and nurses in postpartum care, support breastfeeding, strengthen mother-infant bonding, and promote family-centered care.

Being tested
Infant Massage, Oxytocin Massage, Infant Massage and Oxytocin Massage
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Infant MassageBehavioural

    Mothers will be trained by the researcher to administer standardized infant massage to their own infants. After supervised practice before hospital discharge, mothers will administer infant massage once daily for 4 weeks, for approximately 15 minutes per session. Massage will be performed according to the standardized protocol.

  • Oxytocin MassageBehavioural

    Fathers will be trained by the researcher to administer standardized oxytocin massage to the mothers. After supervised practice before hospital discharge, fathers will administer oxytocin massage once daily for 4 weeks according to the standardized protocol. Each session will last approximately 15-20 minutes.

  • Infant Massage and Oxytocin MassageBehavioural

    Mothers will administer standardized infant massage to their own infants, while fathers will administer standardized oxytocin massage to the mothers. Both interventions will be performed once daily for 4 weeks according to the standardized intervention protocols. Infant massage will last approximately 15 minutes, and oxytocin massage will last approximately 15-20 minutes per session.

Study groups in NCT07867054
Study groupRoleWhat they receive
Control GroupNo interventionMothers and their infants in the control group will not receive any experimental intervention, including oxytocin massage or infant massage, from the researcher. They will continue to receive the hospital's standard routine postpartum care and breastfeeding counseling according to the institutional protocol. Assessments will be conducted before hospital discharge (pre-test) and at 4 weeks postpartum (post-test).
Infant Massage GroupExperimentalMothers in this group will administer infant massage to their own infants once daily for four weeks, for approximately 15 minutes per session, in accordance with the standardized infant massage protocol described above.
Receives: Behavioral: Infant Massage
Oxytocin Massage GroupExperimentalMothers in this group will receive oxytocin massage from their partners/their infants' fathers once daily for four weeks, in accordance with the standardized oxytocin massage protocol described above.
Receives: Behavioral: Oxytocin Massage
Infant Massage and Oxytocin Massage GroupExperimentalBoth interventions will be administered in this group. Oxytocin massage will be administered by the father to the mother, while infant massage will be administered by the mother to the infant. Both interventions will be performed once daily for four weeks in accordance with the standardized intervention protocols described above.
Receives: Behavioral: Infant Massage and Oxytocin Massage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Breastfeeding Quality

    Breastfeeding quality will be assessed using the Bristol Breastfeeding Assessment Tool. Changes in breastfeeding quality from baseline to post-test will be evaluated.Bristol Breastfeeding Assessment Tool The scale is completed by a midwife or nurse based on observation; it consists of four items-"positioning," "latching," "sucking," and "swallowing"-and uses a 3-point Likert scale. Each item is scored on a scale of 0 to 2. The lowest possible score on the scale is 0, and the highest is 8. Low scores indicate that breastfeeding is ineffective, while high scores indicate that breastfeeding is effective.

    Measured: Before hospital discharge (pre-test) and at 4 weeks postpartum (post-test)

  2. Mother-to-infant bonding

    Mother-infant bonding will be assessed using the Mother-Infant Bonding Scale. Changes in Mother-Infant Bonding from baseline to post-test will be evaluated.

    The scale consists of eight items and uses a four-point Likert scale. Scale items are scored on a scale of 0-3, and the total possible score ranges from 0 to 24. Items 1, 4, and 6 on the scale represent positive emotions and are scored as 0, 1, 2, or 3; items 2, 3, 5, 7, and 8 represent negative emotions and are scored as 3, 2, 1, or 0. A high score on the scale indicates a bonding problem between the mother and the infant.

    Measured: Before hospital discharge (pre-test) and at 4 weeks postpartum (post-test)

  3. Breastfeeding self-efficacy

    Breastfeeding self-efficacy will be assessed using the Breastfeeding Self-Efficacy Scale. Changes in breastfeeding self-efficacy from baseline to post-test will be evaluated.Breastfeeding Self-Efficacy Scale It assesses how competent mothers feel regarding breastfeeding. The scale is a 5-point Likert-type scale, ranging from "I am not at all confident" (1 point) to "I am always confident" (5 points). The minimum possible score on the scale is 14, and the maximum is 70. The scale has no cutoff point, and a higher score indicates a higher level of breastfeeding self-efficacy.

    Measured: Before hospital discharge (pre-test) and at 4 weeks postpartum (post-test)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2026
  2. Study start1 Nov 2026 (estimated)
  3. Primary completion1 Jul 2027 (estimated)
  4. Study completion1 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of four parallel groups: (1) standard postpartum care (control group), (2) infant massage applied by the mother, (3) oxytocin back massage applied to the mother by the father, or (4) a combination of infant massage applied by the mother and oxytocin back massage applied to the mother by the father. Participants will remain in their assigned group throughout the study.
Masking
None (open label)
Enrolment
136 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07867054
Sponsor's protocol ID
2026/322
Other IDs
2026/322
Acronym
MIM-BOND
Status last verified
Oct 2026
First submitted
30 Sep 2026
Last updated
14 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is no plan to share individual participant-level data.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in